Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023

Upgrades

Telsey Advisory Group upgraded the previous rating for Allbirds Inc BIRD from Market Perform to Outperform. Allbirds earned $0.17 in the fourth quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Allbirds shows a 52-week-high of $6.12 and a 52-week-low of $1.03. Moreover, at the end of the last trading period, the closing price was at $1.25.

For Stoke Therapeutics Inc STOK, B of A Securities upgraded the previous rating of Underperform to Neutral. Stoke Therapeutics earned $0.65 in the fourth quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Stoke Therapeutics shows a 52-week-high of $22.78 and a 52-week-low of $6.88. Moreover, at the end of the last trading period, the closing price was at $8.89.

According to Northland Capital Markets, the prior rating for Power Integrations Inc POWI was changed from Market Perform to Outperform. Power Integrations earned $0.48 in the fourth quarter, compared to $0.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.98 and a 52-week-low of $59.30. Power Integrations closed at $72.78 at the end of the last trading period.

For Zillow Group Inc ZG, Bernstein upgraded the previous rating of Underperform to Market Perform. In the fourth quarter, Zillow Gr showed an EPS of $0.21, compared to $0.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.48 and a 52-week-low of $26.24. Zillow Gr closed at $42.78 at the end of the last trading period.

According to Raymond James, the prior rating for Carter Bankshares Inc CARE was changed from Market Perform to Outperform. Carter Bankshares earned $0.68 in the first quarter, compared to $0.36 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.84 and a 52-week-low of $12.61. Carter Bankshares closed at $12.85 at the end of the last trading period.

Guggenheim upgraded the previous rating for Biogen Inc BIIB from Neutral to Buy. For the first quarter, Biogen had an EPS of $3.40, compared to year-ago quarter EPS of $3.62. The current stock performance of Biogen shows a 52-week-high of $311.79 and a 52-week-low of $187.22. Moreover, at the end of the last trading period, the closing price was at $304.23.

B of A Securities upgraded the previous rating for Comcast Corp CMCSA from Neutral to Buy. For the first quarter, Comcast had an EPS of $0.92, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $44.62 and a 52-week-low of $28.39. Comcast closed at $41.37 at the end of the last trading period.

For General Motors Co GM, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. General Motors earned $2.21 in the first quarter, compared to $2.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $43.63 and a 52-week-low of $30.34. General Motors closed at $33.04 at the end of the last trading period.

According to HC Wainwright & Co., the prior rating for Argo Blockchain PLC ARBK was changed from Neutral to Buy.

For Iamgold Corp IAG, BMO Capital upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Iamgold had an EPS of $0.02, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $3.23 and a 52-week-low of $0.92. Iamgold closed at $2.85 at the end of the last trading period.

For Otis Worldwide Corp OTIS, Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. For the first quarter, Otis Worldwide had an EPS of $0.80, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $87.33 and a 52-week-low of $62.56. Otis Worldwide closed at $85.30 at the end of the last trading period.

Wells Fargo upgraded the previous rating for Manitowoc Co Inc MTW from Underweight to Equal-Weight. For the fourth quarter, Manitowoc Co had an EPS of $0.74, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $20.20 and a 52-week-low of $7.55. Manitowoc Co closed at $15.29 at the end of the last trading period.

For Alignment Healthcare Inc ALHC, Raymond James upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Alignment Healthcare had an EPS of $0.31, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $19.13 and a 52-week-low of $4.88. At the end of the last trading period, Alignment Healthcare closed at $6.29.

For Logitech International SA LOGI, Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. At the moment, the stock has a 52-week-high of $68.17 and a 52-week-low of $41.82. Logitech International closed at $59.46 at the end of the last trading period.

For Teradata Corp TDC, Guggenheim upgraded the previous rating of Neutral to Buy. Teradata earned $0.35 in the fourth quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $42.79 and a 52-week-low of $28.74. At the end of the last trading period, Teradata closed at $38.71.

Stifel upgraded the previous rating for The Scotts Miracle Gro Co SMG from Hold to Buy. For the first quarter, Scotts Miracle Gro had an EPS of $1.02, compared to year-ago quarter EPS of $0.88. At the moment, the stock has a 52-week-high of $118.03 and a 52-week-low of $39.06. Scotts Miracle Gro closed at $66.81 at the end of the last trading period.

For Essex Property Trust Inc ESS, Piper Sandler upgraded the previous rating of Neutral to Overweight. Essex Property Trust earned $3.65 in the first quarter, compared to $3.37 in the year-ago quarter. The current stock performance of Essex Property Trust shows a 52-week-high of $345.89 and a 52-week-low of $195.03. Moreover, at the end of the last trading period, the closing price was at $219.73.

According to Piper Sandler, the prior rating for AvalonBay Communities Inc AVB was changed from Underweight to Neutral. In the first quarter, AvalonBay Communities showed an EPS of $2.57, compared to $2.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $241.68 and a 52-week-low of $153.07. AvalonBay Communities closed at $180.37 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

OTR Global downgraded the previous rating for Guardant Health Inc GH from Mixed to Negative. Guardant Health earned $1.17 in the fourth quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $65.82 and a 52-week-low of $20.67. At the end of the last trading period, Guardant Health closed at $22.56.

For TAL Education Group TAL, UBS downgraded the previous rating of Buy to Neutral. TAL Education earned $0.02 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $10.45 and a 52-week-low of $2.82. At the end of the last trading period, TAL Education closed at $5.86.

Brookline Capital downgraded the previous rating for NightHawk Biosciences Inc NHWK from Buy to Hold. In the fourth quarter, NightHawk Biosciences showed an EPS of $0.48, compared to $0.54 from the year-ago quarter. The current stock performance of NightHawk Biosciences shows a 52-week-high of $3.42 and a 52-week-low of $0.65. Moreover, at the end of the last trading period, the closing price was at $0.66.

Northcoast Research downgraded the previous rating for Copart Inc CPRT from Buy to Neutral. For the second quarter, Copart had an EPS of $0.61, compared to year-ago quarter EPS of $0.55. The current stock performance of Copart shows a 52-week-high of $79.09 and a 52-week-low of $51.11. Moreover, at the end of the last trading period, the closing price was at $79.05.

Wedbush downgraded the previous rating for IVERIC bio Inc ISEE from Outperform to Neutral. In the fourth quarter, IVERIC bio showed an EPS of $0.47, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.96 and a 52-week-low of $8.88. IVERIC bio closed at $32.89 at the end of the last trading period.

Maxim Group downgraded the previous rating for Siyata Mobile Inc SYTA from Buy to Hold. In the third quarter, Siyata Mobile showed an EPS of $0.03, compared to $0.99 from the year-ago quarter. The current stock performance of Siyata Mobile shows a 52-week-high of $1.62 and a 52-week-low of $0.10. Moreover, at the end of the last trading period, the closing price was at $0.11.

For Shoe Carnival Inc SCVL, Williams Trading downgraded the previous rating of Buy to Hold. Shoe Carnival earned $0.79 in the fourth quarter, compared to $0.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.24 and a 52-week-low of $19.44. Shoe Carnival closed at $23.25 at the end of the last trading period.

According to Raymond James, the prior rating for Valley National Bancorp VLY was changed from Strong Buy to Market Perform. Valley Ntl earned $0.30 in the first quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.06 and a 52-week-low of $7.91. Valley Ntl closed at $9.38 at the end of the last trading period.

According to Janney Montgomery Scott, the prior rating for South Atlantic Bancshares Inc SABK was changed from Buy to Neutral.

For IVERIC bio Inc ISEE, Guggenheim downgraded the previous rating of Buy to Neutral. IVERIC bio earned $0.47 in the fourth quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $32.96 and a 52-week-low of $8.88. At the end of the last trading period, IVERIC bio closed at $32.89.

For ArcBest Corp ARCB, B of A Securities downgraded the previous rating of Neutral to Underperform. For the first quarter, ArcBest had an EPS of $1.58, compared to year-ago quarter EPS of $3.08. The stock has a 52-week-high of $104.87 and a 52-week-low of $65.93. At the end of the last trading period, ArcBest closed at $94.40.

For Principal Financial Group Inc PFG, B of A Securities downgraded the previous rating of Buy to Neutral. In the first quarter, Principal Finl Gr showed an EPS of $1.48, compared to $1.51 from the year-ago quarter. The stock has a 52-week-high of $96.12 and a 52-week-low of $61.06. At the end of the last trading period, Principal Finl Gr closed at $74.69.

Wells Fargo downgraded the previous rating for Doximity Inc DOCS from Overweight to Equal-Weight. Doximity earned $0.22 in the third quarter, compared to $0.29 in the year-ago quarter. The current stock performance of Doximity shows a 52-week-high of $47.40 and a 52-week-low of $22.92. Moreover, at the end of the last trading period, the closing price was at $36.75.

For Exxon Mobil Corp XOM, Goldman Sachs downgraded the previous rating of Buy to Neutral. In the first quarter, Exxon Mobil showed an EPS of $2.83, compared to $2.07 from the year-ago quarter. The current stock performance of Exxon Mobil shows a 52-week-high of $119.92 and a 52-week-low of $80.69. Moreover, at the end of the last trading period, the closing price was at $118.34.

According to JonesTrading, the prior rating for Hanmi Financial Corp HAFC was changed from Buy to Hold. For the first quarter, Hanmi Financial had an EPS of $0.72, compared to year-ago quarter EPS of $0.68. The current stock performance of Hanmi Financial shows a 52-week-high of $27.30 and a 52-week-low of $15.80. Moreover, at the end of the last trading period, the closing price was at $16.16.

See all analyst ratings downgrades.

Initiations

ThinkEquity initiated coverage on Reunion Neuroscience Inc REUN with a Buy rating. The price target for Reunion Neuroscience is set to $5.00. In the third quarter, Reunion Neuroscience showed an EPS of $0.43, compared to $0.51 from the year-ago quarter. The current stock performance of Reunion Neuroscience shows a 52-week-high of $7.62 and a 52-week-low of $0.63. Moreover, at the end of the last trading period, the closing price was at $0.81.

Northland Capital Markets initiated coverage on NEXTracker Inc NXT with a Market Perform rating. The price target for NEXTracker is set to $32.00. The stock has a 52-week-high of $37.83 and a 52-week-low of $28.24. At the end of the last trading period, NEXTracker closed at $31.49.

With a Buy rating, Truist Securities initiated coverage on Edgewise Therapeutics Inc EWTX. The price target seems to have been set at $25.00 for Edgewise Therapeutics. Edgewise Therapeutics earned $0.31 in the fourth quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.33 and a 52-week-low of $5.41. Edgewise Therapeutics closed at $8.77 at the end of the last trading period.

With a Buy rating, Truist Securities initiated coverage on Coherus BioSciences Inc CHRS. The price target seems to have been set at $24.00 for Coherus BioSciences. In the fourth quarter, Coherus BioSciences showed an EPS of $0.60, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $14.03 and a 52-week-low of $5.59. At the end of the last trading period, Coherus BioSciences closed at $7.23.

With a Buy rating, Truist Securities initiated coverage on Treace Medical Concepts Inc TMCI. The price target seems to have been set at $33.00 for Treace Medical Concepts. Treace Medical Concepts earned $0.08 in the fourth quarter, compared to $0.12 in the year-ago quarter. The current stock performance of Treace Medical Concepts shows a 52-week-high of $27.97 and a 52-week-low of $12.49. Moreover, at the end of the last trading period, the closing price was at $24.49.

With a Buy rating, Guggenheim initiated coverage on Endeavor Group Holdings Inc EDR. The price target seems to have been set at $33.00 for Endeavor Gr Hldgs. For the fourth quarter, Endeavor Gr Hldgs had an EPS of $0.72, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $26.26 and a 52-week-low of $17.43. At the end of the last trading period, Endeavor Gr Hldgs closed at $25.78.

Guggenheim initiated coverage on MoonLake Immunotherapeutics MLTX with a Buy rating. The price target for MoonLake is set to $51.00. For the fourth quarter, MoonLake had an EPS of $0.31, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $26.24 and a 52-week-low of $4.37. MoonLake closed at $21.30 at the end of the last trading period.

With an Outperform rating, SVB Leerink initiated coverage on Danaher Corp DHR. The price target seems to have been set at $300.00 for Danaher. Danaher earned $2.36 in the first quarter, compared to $2.76 in the year-ago quarter. The stock has a 52-week-high of $303.81 and a 52-week-low of $227.00. At the end of the last trading period, Danaher closed at $236.91.

With a Buy rating, B of A Securities initiated coverage on Immunovant Inc IMVT. The price target seems to have been set at $26.00 for Immunovant. For the third quarter, Immunovant had an EPS of $0.49, compared to year-ago quarter EPS of $0.36. The stock has a 52-week-high of $20.24 and a 52-week-low of $3.15. At the end of the last trading period, Immunovant closed at $16.14.

With a Buy rating, HC Wainwright & Co. initiated coverage on Invivyd Inc IVVD. The price target seems to have been set at $5.00 for Invivyd. Invivyd earned $0.41 in the fourth quarter, compared to $0.77 in the year-ago quarter. The current stock performance of Invivyd shows a 52-week-high of $4.89 and a 52-week-low of $1.03. Moreover, at the end of the last trading period, the closing price was at $1.10.

HC Wainwright & Co. initiated coverage on Kineta Inc KA with a Buy rating. The price target for Kineta is set to $8.00. NoneAt the moment, the stock has a 52-week-high of $9.00 and a 52-week-low of $1.00. Kineta closed at $3.97 at the end of the last trading period.

With a Buy rating, Goldman Sachs initiated coverage on TD Synnex Corp SNX. The price target seems to have been set at $101.00 for TD Synnex. TD Synnex earned $2.93 in the first quarter, compared to $3.03 in the year-ago quarter. The stock has a 52-week-high of $111.57 and a 52-week-low of $79.14. At the end of the last trading period, TD Synnex closed at $89.04.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!